FRINK Linked Data Fragments server

Matches in SemOpenAlex for { <https://semopenalex.org/work/W4301586052> ?p ?o ?g. }

• W4301586052 abstract "Although some previous studies have indicated that extracellular vesicles (EVs) secreted from miRNA-modified mesenchymal stem cells (MSCs) may be more effective as compared with control EVs in the treatment of rats with spinal cord injuries (SCI), the efficacy of this treatment modality remains controversial.The current study comprehensively evaluated the efficacy of different administered doses of EVs, including miRNA-overexpressing MSCs-derived EVs, among SCI rats. The efficacy of EVs' treatment was evaluated in different SCI models to provide evidence for preclinical trials.We extensively searched the following databases to identify relevant studies: PubMed, Embase, Scopus, The Cochrane Library, and Web of Science (from inception to July 20, 2022). Two trained investigators independently screened literature, extracted the data, and evaluated literature quality.Thirteen studies were included in this network meta-analysis. The results demonstrated that miRNA-overexpressing MSCs-derived EVs (100 and 200 μg of total protein of EVs) significantly improved hind limb motor function in rats at early stages of SCI (i.e., at 3 days after injury) as compared with EVs (100 and 200 μg of total protein of EVs, respectively). However, in the middle and late stages (14 and 28 days), there were no statistically significant differences between EVs with 200 μg dosages and miRNA-loaded EVs with 100 μg dosages. In the late stages (28 days), there were no statistically significant differences between EVs with 100 μg dosages and miRNA-loaded EVs with 200 μg dosages. We found that miRNA-overexpressing MSCs-derived EVs significantly improved motor function among early-stage SCI rats in a compression and contusion model (3 days) as compared with MSCs-derived EVs and miRNA-overexpressing MSCs-derived EVs likewise significantly improved motor function among SCI rats in a contusion model at middle and late stages (14 and 28 days).Our results suggest that miRNA-overexpressing MSCs-derived EVs (200 μg of total protein of EVs) may be the best choice for the effective treatment of SCI, and miRNA-overexpressing MSCs-derived EVs may likewise be the best choice for treating contusions. However, there are some risks of bias in our included studies, and the mechanisms underlying the efficacy of EVs remain unclear.Systematic review registration: https://www.crd.york.ac.uk/prospero/display_record.php?RecordID=282051, identifier: CRD42021282051." @default.
• W4301586052 created "2022-10-05" @default.
• W4301586052 creator A5014724492 @default.
• W4301586052 creator A5016622592 @default.
• W4301586052 creator A5025024898 @default.
• W4301586052 creator A5033487917 @default.
• W4301586052 creator A5049785334 @default.
• W4301586052 creator A5060231992 @default.
• W4301586052 creator A5067946620 @default.
• W4301586052 creator A5080793068 @default.
• W4301586052 date "2022-10-05" @default.
• W4301586052 modified "2023-09-30" @default.
• W4301586052 title "Efficacy of miRNA-modified mesenchymal stem cell extracellular vesicles in spinal cord injury: A systematic review of the literature and network meta-analysis" @default.
• W4301586052 cites W1577089616 @default.
• W4301586052 cites W1983325630 @default.
• W4301586052 cites W1998282284 @default.
• W4301586052 cites W2010699829 @default.
• W4301586052 cites W2035120744 @default.
• W4301586052 cites W2040557955 @default.
• W4301586052 cites W2058571677 @default.
• W4301586052 cites W2071625709 @default.
• W4301586052 cites W2085803274 @default.
• W4301586052 cites W2116475791 @default.
• W4301586052 cites W2129821518 @default.
• W4301586052 cites W2155569675 @default.
• W4301586052 cites W2273372601 @default.
• W4301586052 cites W2484283047 @default.
• W4301586052 cites W2807425198 @default.
• W4301586052 cites W2888380698 @default.
• W4301586052 cites W2900756811 @default.
• W4301586052 cites W2901725398 @default.
• W4301586052 cites W2933304441 @default.
• W4301586052 cites W2935822819 @default.
• W4301586052 cites W2936948584 @default.
• W4301586052 cites W2970026792 @default.
• W4301586052 cites W2985641903 @default.
• W4301586052 cites W2992413241 @default.
• W4301586052 cites W2995128645 @default.
• W4301586052 cites W3009920102 @default.
• W4301586052 cites W3015349144 @default.
• W4301586052 cites W3023464051 @default.
• W4301586052 cites W3044547779 @default.
• W4301586052 cites W3088704361 @default.
• W4301586052 cites W3092277531 @default.
• W4301586052 cites W3113735845 @default.
• W4301586052 cites W3118615836 @default.
• W4301586052 cites W3126534957 @default.
• W4301586052 cites W3128345208 @default.
• W4301586052 cites W3128837528 @default.
• W4301586052 cites W3144305753 @default.
• W4301586052 cites W3146110003 @default.
• W4301586052 cites W3153160297 @default.
• W4301586052 cites W3178971826 @default.
• W4301586052 cites W3183186264 @default.
• W4301586052 cites W3185306160 @default.
• W4301586052 cites W3190680235 @default.
• W4301586052 cites W3203118887 @default.
• W4301586052 cites W3203393196 @default.
• W4301586052 cites W3203421818 @default.
• W4301586052 cites W3207775396 @default.
• W4301586052 cites W3211189741 @default.
• W4301586052 cites W3213200983 @default.
• W4301586052 cites W4200447179 @default.
• W4301586052 cites W4206323153 @default.
• W4301586052 cites W4206786285 @default.
• W4301586052 cites W4220700514 @default.
• W4301586052 cites W4220800092 @default.
• W4301586052 cites W4221093274 @default.
• W4301586052 doi "https://doi.org/10.3389/fnins.2022.989295" @default.
• W4301586052 hasPubMedId "https://pubmed.ncbi.nlm.nih.gov/36278023" @default.
• W4301586052 hasPublicationYear "2022" @default.
• W4301586052 type Work @default.
• W4301586052 citedByCount "3" @default.
• W4301586052 countsByYear W43015860522023 @default.
• W4301586052 crossrefType "journal-article" @default.
• W4301586052 hasAuthorship W4301586052A5014724492 @default.
• W4301586052 hasAuthorship W4301586052A5016622592 @default.
• W4301586052 hasAuthorship W4301586052A5025024898 @default.
• W4301586052 hasAuthorship W4301586052A5033487917 @default.
• W4301586052 hasAuthorship W4301586052A5049785334 @default.
• W4301586052 hasAuthorship W4301586052A5060231992 @default.
• W4301586052 hasAuthorship W4301586052A5067946620 @default.
• W4301586052 hasAuthorship W4301586052A5080793068 @default.
• W4301586052 hasBestOaLocation W43015860521 @default.
• W4301586052 hasConcept C104317684 @default.
• W4301586052 hasConcept C118552586 @default.
• W4301586052 hasConcept C126322002 @default.
• W4301586052 hasConcept C142724271 @default.
• W4301586052 hasConcept C145059251 @default.
• W4301586052 hasConcept C162156334 @default.
• W4301586052 hasConcept C198826908 @default.
• W4301586052 hasConcept C2776478404 @default.
• W4301586052 hasConcept C2778334475 @default.
• W4301586052 hasConcept C2780775167 @default.
• W4301586052 hasConcept C2992929900 @default.
• W4301586052 hasConcept C55493867 @default.
• W4301586052 hasConcept C60644358 @default.
• W4301586052 hasConcept C71924100 @default.
• W4301586052 hasConcept C86803240 @default.
• W4301586052 hasConcept C95190672 @default.

• next